Cargando…
SMRI: A New Method for siRNA Design for COVID-19 Therapy
First discovered in Wuhan, China, SARS-CoV-2 is a highly pathogenic novel coronavirus, which rapidly spread globally and became a pandemic with no vaccine and limited distinctive clinical drugs available till March 13th, 2020. Ribonucleic Acid interference (RNAi) technology, a gene-silencing technol...
Autores principales: | Chen, Meng-Xin, Zhu, Xiao-Dong, Zhang, Hao, Liu, Zhen, Liu, Yuan-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374573/ https://www.ncbi.nlm.nih.gov/pubmed/35992496 http://dx.doi.org/10.1007/s11390-021-0826-x |
Ejemplares similares
-
siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010) -
Rational design of microRNA–siRNA chimeras for multifunctional target suppression
por: Jiang, Zhou, et al.
Publicado: (2013) -
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018) -
sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database
por: Shah, Jyoti K, et al.
Publicado: (2007) -
Design of New Polyaspartamide Copolymers for siRNA Delivery in Antiasthmatic Therapy
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2020)